내부 외상 고정 기기 시장 보고서 : 제품별, 재료별, 최종사용자별, 지역별(2026-2034년)

The global internal trauma fixation device market size reached USD 11.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 15.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.90% during 2026-2034. The market is notably propelled by accelerating demand for technological innovations in device material and designing, nominally invasive surgeries, and an escalating geriatric population. In addition, such factors are improving patient outcomes, enhancing recovery periods, and boosting the adoption of cutting-edge trauma fixation solutions globally, thereby propelling the market growth.

INTERNAL TRAUMA FIXATION DEVICE MARKET ANALYSIS:

• Major Market Drivers: The market is principally driven by the heightening incidents of orthopedic diseases and fractures. Global rise in aging population is also a key driver for market growth as it contributes to the elevation of injury rates. Moreover, innovations in medical technology have significantly enhanced surgical outcomes. The magnifying awareness regarding efficient treatments and escalating healthcare expenditure in developing countries are also bolstering market growth. In addition, amplified emphasis on minimally invasive surgery solutions further prompts the adoption of such devices, improving patient post-surgery recovery times and lowering stay periods at the hospital.
• Key Market Trends: One of the key trends observed in the global market include technological advancements in 3D printing and biomaterial-based implants. Such innovations are significantly improving device strength as well as customization and enhancing surgery outcomes. Moreover, surgeons are actively leveraging minimally invasive techniques, which are propelling demand for versatile, small devices. In addition, the innovation of bioabsorbable implants is gaining momentum as they lower the need for secondary surgeries, a crucial factor influencing market expansion. Furthermore, the surge in digital health solutions is also facilitating post-operative recovery processes.
• Geographical Trends: North America has established itself as the dominant region in the global internal trauma fixation devices market, chiefly driven by robust healthcare infrastructure and elevated healthcare expenditure. The presence of well-established companies in this region, combined with a magnified aging population susceptible to fractures, fosters sustained demand. Moreover, beneficial reimbursement protocols and increased adoption of advanced medical technologies improve the market expansion in the region. In addition, high investments in research and development and heightening patient awareness further fortify North America's dominance.
• Competitive Landscape: Some of the major market players in the internal trauma fixation device industry include Arthrex Inc., B. Braun Melsungen AG, Globus Medical Inc., Johnson & Johnson Private Limited, Medartis AG, Orthofix Medical Inc., Orthopaedic Implant Company, OsteoMed (Berkshire Hathaway Inc.), Smith & Nephew plc, Stryker Corporation, Zimmer Biomet., among many others.
• Challenges and Opportunities: The market experiences challenges such as regulatory complications and elevated costs of advanced devices that restrict adoption in price-sensitive nations. In addition, post-surgical issues pose challenges to patient recovery, affecting market growth. However, such challenges provide opportunities for development in effective, cost-efficient devices and improved safety attributes. Moreover, widening healthcare access in emerging economies also offers a substantial opportunity for manufacturers to tap into unaddressed populations, facilitating future market growth.

INTERNAL TRAUMA FIXATION DEVICE MARKET TRENDS:

Increasing Demand for Minimally Invasive Surgeries

The escalating preference for minimally invasive surgeries is one of the key trends significantly impacting the global market growth. Such procedures provide lowered post-operative issues and quicker recovery times. According to a research article published in the journal of Brain and Spine, in March 2024, a study result indicated that in comparison to traditional open surgery, minimally invasive surgery (MIS) for spinal fractures exhibited better life quality, lowered back pain, and less disability. Furthermore, only 30% of MIS patients needed pain medication, compared to 54% of individuals who underwent traditional open surgery. Moreover, technological innovations, such as more effective and compact fixation devices, are substantially steering this trend. In addition, numerous healthcare providers and surgeons are currently leveraging these devices for treating traumas as well as fractures, especially in old-aged patients, which is further contributing to the internal trauma fixation device demand and overall enhancement of patient outcomes.

Increase in Geriatric Population

The global elevation in the aging population is substantially aiding the market expansion for internal trauma fixation device. According to the United Nations, the number of individuals aged 80 years or older are observed to be growing at an accelerated rate. Furthermore, it is projected that in the year 2050, number of individuals aged 65 or older will reach around 1.6 billion. The demand for efficient trauma fixation solutions is rapidly fueling among this segment of population as the old-aged individuals are more prone to orthopedic disorders and fractures. Moreover, the increasing prevalence of bone-associated diseases, like osteoporosis, and amplified life expectancy, are further fueling the adoption of these fixation devices. In addition, this trend is anticipated to bolster as healthcare organizations are actively emphasizing on enhancing the quality of life for elderly population, which, ultimately, boosts the global internal trauma fixation device market growth.

Technological Innovations in Fixation Devices

Technological advancements in the materials and design of internal trauma fixation devices are significantly steering the global market dynamics. The development of 3D-printed and bioabsorbable implants, coupled with improved navigation and imaging systems, is enhancing device incorporation as well as surgical outcomes. For instance, in April 2023, University of Central Florida developed bioabsorbable rods, screws, pins, and various other implants using magnesium composites for better bone healing. These bioabsorbable implants are also incorporated with nanoparticles to accelerate bone regeneration. In addition, such advancements permit for more patient-specific, accurate treatment processes, lowering the demand for follow-up surgeries and improving recovery periods. Moreover, constant research and development in this market is expected to further result in innovation of more efficient trauma care solution, thereby contributing to the positive internal trauma fixation device market outlook.

INTERNAL TRAUMA FIXATION DEVICE MARKET SEGMENTATION:

Breakup by Product:

• Closure Device
  • Plates and Screws
  • Wires
  • Clips and Pins
  • Rods and Nails
  • Cables
• Bone Cement

Closure device (plates and screws) accounts for the majority of the market share

According to the internal trauma fixation device market forecast, plates and screws are anticipated to sustain their dominance as closure device mainly because of their exceptional capability to offer durable and robust fixation for various types of fractures, which makes them requisite in surgical processes. Advancements in materials and designs have significantly enhanced their performance, resulting in a quicker recovery time and minimized complications. In addition, plates and screws are extensively preferred due to their versatile nature in mitigating complicated bone fractures, guaranteeing accuracy and long-term dependability for individuals undergoing trauma fixation surgeries.

Breakup by Material:

• Stainless Steel
• Nitinol
• Titanium
• Tritium
• Polyether Ether Ketone (PEEK)

Stainless steel holds the largest share of the industry

As per the internal trauma fixation device market report, stainless steel is a widely utilized material in this market due to its cost-efficiency, durability, and robustness. Its high resistance against corrosion establishes it as a suitable material for long-term usage in implants, lowering the chances of infection in patients. In addition, the widespread availability and affordability of stainless steel position it as a preferrable material for numerous healthcare providers, especially in regions with restricted budgets. In spite of innovations in alternative materials, stainless steel continues to be depended upon for trauma fixation devices globally.

Breakup by End User:

• Hospitals
• Orthopedic Surgical Centers
• Trauma Centers
• Ambulatory Centers

Hospitals represent the leading market segment

According to the internal trauma fixation device market research report, hospitals have emerged as the leading end-user segment in the global market. They efficiently manage the majority of trauma cases demand surgical mediation, making them major consumers of such devices. In addition, the availability of cutting-edge medical facilities, extensive post-operative care, and trained surgeons in hospitals supports their market domination. Moreover, the increasing prevalence of trauma-related injuries, such as internal bleeding, organ damage, and bone fractures, fosters a steady demand for screws, plates, and other fixation devices within the hospital premises globally. According to a research article published in August 2023, by 2050, the annual cases of hip fractures around the world are anticipated to increase to 5-21 million.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest internal trauma fixation device market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for internal trauma fixation device.

North America is leading the global internal trauma fixation market, majorly supported by upgraded healthcare systems, increasing population of aged individuals, and elevated medical spendings. The region notably profits from robust research and development projects, coupled with beneficial regulatory policies. Moreover, the rising cases of various orthopedic conditions as well as fractures, along with easy access to advanced medical facilities, significantly fuel the demand for such devices in the region. As per recent study data, orthopedic conditions such as anterior cruciate ligament ruptures are commonly observed in trauma victims, with 100,000 to 200,000 such incidents recorded annually in the U.S. In addition, the heightening awareness regarding early diagnosis as well as treatment of internal trauma further strengthens North America's position as the dominant region in the global market for internal trauma fixation device.

COMPETITIVE LANDSCAPE:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the internal trauma fixation device industry include Arthrex Inc., B. Braun Melsungen AG, Globus Medical Inc., Johnson & Johnson Private Limited, Medartis AG, Orthofix Medical Inc., Orthopaedic Implant Company, OsteoMed (Berkshire Hathaway Inc.), Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet. ()
• The competitive landscape is characterized by intense competition, with major players actively emphasizing on strategic collaborations, certifications and clearances from regulatory bodies, and product advancements to attain a competitive advantage. For instance, in October 2023, the TriLeap Lower Extremity Anatomic Plating System, developed by DePuy Synthes, a Johnson & Johnson company, was granted clearance by the US FDA and is anticipated to launch in 2024. This plating system can be utilized by surgeons for bone stabilization during fractures, bunionectomies, and osteotomies of the ankle or foot. Various companies are currently investing in research and development activities to enhance device efficiency and proliferate their product offerings. Moreover, well-established leaders in the market are also participating in acquisitions and mergers deals to fortify their foothold and tap into new markets. Whereas regional players are emphasizing on providing cost-efficient solution, addressing the needs of price-sensitive markets and extending their reach.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the global internal trauma fixation device market?

2. What is the expected growth rate of the global internal trauma fixation device market during 2026-2034?

3. What are the key factors driving the global internal trauma fixation device market?

4. What has been the impact of COVID-19 on the global internal trauma fixation device market?

5. What is the breakup of the global internal trauma fixation device market based on the product?

6. What is the breakup of the global internal trauma fixation device market based on the material?

7. What is the breakup of the global internal trauma fixation device market based on the end user?

8. What are the key regions in the global internal trauma fixation device market?

9. Who are the key players/companies in the global internal trauma fixation device market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Internal Trauma Fixation Device Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Closure Device
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Plates and Screws
    • 6.1.2.2 Wires
    • 6.1.2.3 Clips and Pins
    • 6.1.2.4 Rods and Nails
    • 6.1.2.5 Cables
  • 6.1.3 Market Forecast
• 6.2 Bone Cement
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Material

• 7.1 Stainless Steel
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Nitinol
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Titanium
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Tritium
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Polyether Ether Ketone (PEEK)
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Orthopedic Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Trauma Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Ambulatory Centers
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Arthrex Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 SWOT Analysis
  • 14.3.2 B. Braun Melsungen AG
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 SWOT Analysis
  • 14.3.3 Globus Medical Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Johnson & Johnson Private Limited
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Medartis AG
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Orthofix Medical Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Orthopaedic Implant Company
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 OsteoMed (Berkshire Hathaway Inc.)
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Smith & Nephew plc
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Stryker Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Zimmer Biomet
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis